Erika Wallender

712 total citations
26 papers, 464 citations indexed

About

Erika Wallender is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Erika Wallender has authored 26 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 7 papers in Infectious Diseases and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Erika Wallender's work include Malaria Research and Control (14 papers), Mosquito-borne diseases and control (7 papers) and Computational Drug Discovery Methods (4 papers). Erika Wallender is often cited by papers focused on Malaria Research and Control (14 papers), Mosquito-borne diseases and control (7 papers) and Computational Drug Discovery Methods (4 papers). Erika Wallender collaborates with scholars based in United States, Uganda and Tanzania. Erika Wallender's co-authors include Jonathan S. Yoder, Virginia A. Roberts, Joan Brunkard, Elizabeth C. Ailes, Francesca Aweeka, Radojka M. Savić, Emma Hughes, Philip J. Rosenthal, Maria Garcia‐Cremades and Anne F. Luetkemeyer and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Erika Wallender

24 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Wallender United States 11 155 124 76 67 64 26 464
Sophie Namasopo Canada 17 409 2.6× 81 0.7× 17 0.2× 135 2.0× 38 0.6× 47 750
Shubham Sharma Canada 10 71 0.5× 23 0.2× 44 0.6× 33 0.5× 6 0.1× 18 367
Hailan Yang China 12 86 0.6× 115 0.9× 41 0.5× 39 0.6× 3 0.0× 37 635
Femke van der Sman-de Beer Netherlands 11 49 0.3× 51 0.4× 12 0.2× 31 0.5× 7 0.1× 13 494
Sima Besharat Iran 16 68 0.4× 86 0.7× 111 1.5× 265 4.0× 3 0.0× 115 802
Arun Joshi India 15 125 0.8× 34 0.3× 16 0.2× 107 1.6× 3 0.0× 79 719
Sylvain Lother Canada 10 49 0.3× 197 1.6× 121 1.6× 61 0.9× 20 0.3× 27 383
Angela Park United States 14 67 0.4× 119 1.0× 49 0.6× 109 1.6× 3 0.0× 28 513
I. Adam Sudan 17 234 1.5× 30 0.2× 31 0.4× 29 0.4× 36 0.6× 29 549
Jeyamani Ramachandran India 15 22 0.1× 145 1.2× 25 0.3× 379 5.7× 15 0.2× 55 785

Countries citing papers authored by Erika Wallender

Since Specialization
Citations

This map shows the geographic impact of Erika Wallender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Wallender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Wallender more than expected).

Fields of papers citing papers by Erika Wallender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Wallender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Wallender. The network helps show where Erika Wallender may publish in the future.

Co-authorship network of co-authors of Erika Wallender

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Wallender. A scholar is included among the top collaborators of Erika Wallender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Wallender. Erika Wallender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reses, Hannah E., Heather Dubendris, Emily Wong, et al.. (2024). Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024. MMWR Morbidity and Mortality Weekly Report. 73(46). 1052–1057. 4 indexed citations
2.
Wallender, Erika, John M. Miller, Travis R. Porter, et al.. (2024). Malaria community case management usage and quality of malaria care in a moderate Plasmodium falciparum burden region of Chadiza District, Zambia. Malaria Journal. 23(1). 226–226. 1 indexed citations
3.
Ali, Ali M., Erika Wallender, Emma Hughes, Grant Dorsey, & Radojka M. Savić. (2023). Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis. CPT Pharmacometrics & Systems Pharmacology. 12(5). 656–667. 2 indexed citations
4.
Roh, Michelle E., Issaka Zongo, Alassane Haro, et al.. (2023). Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study. The Journal of Infectious Diseases. 228(7). 926–935. 8 indexed citations
5.
Kajubi, Richard, Erika Wallender, Norah Mwebaza, et al.. (2023). Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. Antimicrobial Agents and Chemotherapy. 67(4). e0142722–e0142722. 2 indexed citations
6.
Wallender, Erika, Georgina Peacock, Melinda Wharton, & Rochelle P. Walensky. (2023). Uninsured and Not Immune — Closing the Vaccine-Coverage Gap for Adults. New England Journal of Medicine. 389(3). 193–195. 5 indexed citations
7.
Wallender, Erika, Ali M. Ali, Emma Hughes, et al.. (2021). Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children. Nature Communications. 12(1). 6714–6714. 11 indexed citations
8.
Hughes, Emma, Erika Wallender, Richard Kajubi, et al.. (2021). Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women. Clinical Infectious Diseases. 75(3). 406–415. 9 indexed citations
9.
Hughes, Emma, Erika Wallender, Ali M. Ali, Prasanna Jagannathan, & Radojka M. Savić. (2021). Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations. Clinical Pharmacology & Therapeutics. 110(4). 926–940. 10 indexed citations
10.
Mwebaza, Norah, Richard Kajubi, Florence Marzan, et al.. (2020). Determination of piperaquine concentration in human plasma and the correlation of capillary versus venous plasma concentrations. PLoS ONE. 15(5). e0233893–e0233893. 9 indexed citations
11.
Budak, Jehan Z, Cristina Brickman, Erika Wallender, et al.. (2020). Response to: Is Burnout Infectious? Understanding Drivers of Burnout and Job Satisfaction Among Academic Infectious Diseases Physicians. Open Forum Infectious Diseases. 7(4).
12.
Kajubi, Richard, Liusheng Huang, Erika Wallender, et al.. (2019). Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin‐Piperaquine as Malaria Chemoprevention. Clinical Pharmacology & Therapeutics. 106(6). 1310–1318. 4 indexed citations
13.
Wallender, Erika, Nan Zhang, Melissa D. Conrad, et al.. (2018). Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda. Antimicrobial Agents and Chemotherapy. 63(2). 13 indexed citations
14.
Rutledge, Caleb, et al.. (2017). Salmonella Infection After Craniotomy. Cureus. 9(8). e1566–e1566. 1 indexed citations
15.
Wallender, Erika, Katarina Vučićević, Prasanna Jagannathan, et al.. (2017). Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus–Infected Women Receiving Efavirenz. The Journal of Infectious Diseases. 217(6). 964–972. 14 indexed citations
16.
Conrad, Melissa D., Stephen Tukwasibwe, Jennifer Legac, et al.. (2017). Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance–Mediating Polymorphisms in Uganda. The Journal of Infectious Diseases. 216(8). 1008–1017. 24 indexed citations
17.
Chastain, Cody A., Susan E. Beekmann, Erika Wallender, et al.. (2015). Hepatitis C Management and the Infectious Diseases Physician: A Survey of Current and Anticipated Practice Patterns: Figure 1.. Clinical Infectious Diseases. 61(5). 792–794. 8 indexed citations
18.
Hawkins, Claudia, Oche Agbaji, Chloe L. Thio, et al.. (2013). Assessment of Liver Fibrosis by Transient Elastography in Patients With HIV and Hepatitis B Virus Coinfection in Nigeria. Clinical Infectious Diseases. 57(12). e189–e192. 26 indexed citations
19.
Johnson, Douglas B., Erika Wallender, Daniel N. Cohen, et al.. (2013). Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy. Cancer Immunology Research. 1(6). 373–377. 72 indexed citations
20.
Wallender, Erika, Elizabeth C. Ailes, Jonathan S. Yoder, Virginia A. Roberts, & Joan Brunkard. (2013). Contributing Factors to Disease Outbreaks Associated with Untreated Groundwater. Ground Water. 52(6). 886–897. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026